Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (6): 573-577,582    DOI: 10.19485/j.cnki.issn2096-5087.2026.06.008
  论著 本期目录 | 过刊浏览 | 高级检索 |
甘油三酯-葡萄糖-衰弱指数与中老年人糖尿病发病风险的关联研究
谢江1,2, 王雨凤2, 张娟2, 宋英楠2, 罗玲1, 陶美伊2, 苏晚英1
1.湖南省人民医院(湖南师范大学附属第一医院),湖南 长沙 410005;
2.湖南师范大学医学部护理学院,湖南 长沙 410013
Association between the triglyceride-glucose-frailty index and the risk of diabetes mellitus among middle-aged and elderly population
XIE Jiang1,2, WANG Yufeng2, ZHANG Juan2, SONG Yingnan2, LUO Ling1, TAO Meiyi2, SU Wanying1
1. Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, China;
2. School of Nursing, Faculty of Medicine, Hunan Normal University, Changsha, Hunan 410013, China
全文: PDF(863 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨甘油三酯-葡萄糖-衰弱指数与中老年人糖尿病发病风险的关联,为中老年人糖尿病风险筛查和管理提供参考。方法 基于中国健康与养老追踪调查(CHARLS)2011—2018年调查资料,选择基线调查年龄≥45岁且无糖尿病的中老年人为研究对象,收集人口学信息、生活方式和实验室检测等资料。采用甘油三酯和空腹血糖指标计算甘油三酯-葡萄糖指数,采用29项健康缺陷累积模型计算衰弱指数,2项指数相乘计算甘油三酯-葡萄糖-衰弱指数,并按四分位数分为4组。采用多因素Cox比例风险回归模型分析甘油三酯-葡萄糖-衰弱指数与糖尿病发病风险的关联,采用限制性立方样条模型分析两者的剂量-反应关系。结果 纳入5 246人,其中男性2 364人,占45.06%;女性2 882人,占54.94%。年龄为(58.38±8.78)岁。甘油三酯-葡萄糖-衰弱指数MQR)为0.78(1.13)。2018年报告糖尿病发病452例,累积发病率为8.62%。多因素Cox比例风险回归分析结果显示,调整人口学特征、生活方式和生化指标等混杂因素后,甘油三酯-葡萄糖-衰弱指数每升高1个标准差,糖尿病发病风险增加37.5%(HR=1.375,95%CI:1.278~1.479);以Q1组为参照,Q2、Q3和Q4组糖尿病发病风险分别增加50.8%(HR=1.508,95%CI:1.072~2.123)、91.3%(HR=1.913,95%CI:1.380~2.651)和241.6%(HR=3.416,95%CI:2.499~4.671),呈上升趋势(P趋势<0.05)。限制性立方样条分析结果显示,甘油三酯-葡萄糖-衰弱指数与糖尿病发病风险呈非线性关系(P<0.05)。结论 甘油三酯-葡萄糖-衰弱指数升高可增加中老年人糖尿病发病风险,两者呈非线性剂量-反应关系。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
谢江
王雨凤
张娟
宋英楠
罗玲
陶美伊
苏晚英
关键词 甘油三酯-葡萄糖指数衰弱指数糖尿病中老年人    
AbstractObjective To explore the association between the triglyceride-glucose-frailty index and the risk of diabetes mellitus among middle-aged and elderly population, so as to provide the evidence for diabetes mellitus risk screening and management among middle-aged and elderly population. Methods Based on data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018, middle-aged and elderly individuals aged ≥45 years without diabetes mellitus at baseline were selected as study participants. Demographic characteristics, lifestyles, and laboratory test data were collected. The triglyceride-glucose index was calculated using triglyceride and fasting blood glucose levels, and the frailty index was derived from a 29-item health deficit accumulation model. The triglyceride-glucose-frailty index was obtained by multiplying the two indices, and participants were divided into four groups according to quartiles. Association between the triglyceride-glucose-frailty index and diabetes mellitus incidence risk was analyzed using a multivariable Cox proportional hazards regression model, and the dose-response relationship was assessed using a restricted cubic spline model. Results A total of 5 246 participants were included, including 2 364 males (45.06%) and 2 882 females (54.94%). The mean age was (58.38±8.78) years. The median of the triglyceride-glucose-frailty index was 0.78 (interquartile range, 1.13). By 2018, 452 diabetes mellitus cases were identified, with a cumulative incidence of 8.62%. Multivariable Cox proportional hazards regression analysis showed that, after adjusting for demographic characteristics, lifestyle factors, and biochemical indicators, each one-standard-deviation increase of the triglyceride-glucose-frailty index was associated with a 37.5% higher risk of diabetes mellitus incidence (HR=1.375, 95%CI: 1.278-1.479). Compared with the Q1 group, the risk increased by 50.8% (HR=1.508, 95%CI: 1.072-2.123), 91.3% (HR=1.913, 95%CI: 1.380-2.651) and 241.6% (HR=3.416, 95%CI: 2.499-4.671) in the Q2, Q3 and Q4 groups, respectively, presenting an upward trend (Pfor trend <0.05). Restricted cubic spline analysis showed a non-linear relationship between the triglyceride-glucose-frailty index and diabetes mellitus incidence risk (P<0.05). Conclusion The triglyceride-glucose-frailty index was positively associated with diabetes mellitus risk among middle-aged and elderly population, and a nonlinear dose-response relationship was observed between the two.
Key wordstriglyceride-glucose index    frailty index    diabetes mellitus    middle-aged and elderly population
收稿日期: 2026-01-14      修回日期: 2026-05-19     
中图分类号:  R587.1  
基金资助:湖南省自然科学基金项目(2024JJ9281)
作者简介: 谢江,硕士研究生在读,护理学专业
通信作者: 苏晚英,E-mail:470266479@qq.com   
引用本文:   
谢江, 王雨凤, 张娟, 宋英楠, 罗玲, 陶美伊, 苏晚英. 甘油三酯-葡萄糖-衰弱指数与中老年人糖尿病发病风险的关联研究[J]. 预防医学, 2026, 38(6): 573-577,582.
XIE Jiang, WANG Yufeng, ZHANG Juan, SONG Yingnan, LUO Ling, TAO Meiyi, SU Wanying. Association between the triglyceride-glucose-frailty index and the risk of diabetes mellitus among middle-aged and elderly population. Preventive Medicine, 2026, 38(6): 573-577,582.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.06.008      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I6/573
[1] CHO N H,SHAW J E,KARURANGA S,et al.IDF Diabetes Atlas:global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018,138:271-281.
[2] 王慧,高霞,朱晓云,等.社区2型糖尿病患者血糖控制达标的影响因素分析[J].预防医学,2024,36(5):423-427.
[3] KUANG M B,YANG R J,HUANG X,et al.Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes:an analysis using time-dependent receiver operating characteristics[J/OL].J Transl Med,2023,21(1)[2026-05-19].https://doi.org/10.1186/s12967-023-04159-7.
[4] NNAMUDI A C,ORHUE N J,IJEH I I,et al.Finnish diabetes risk score outperformed triglyceride-glucose index in diabetes risk prediction[J].J Diabetes Metab Disord,2023,22(2):1337-1345.
[5] CENGIZ B E,OZER N T,CENGIZ C B,et al.The concurrent challenges of sarcopenia and frailty:a 5-year mortality risk evaluation in geriatric patients with type 2 diabetes mellitus[J/OL].Diabetes Metab J,2025[2026-05-19].https://doi.org/10.4093/dmj.2025.0077.
[6] ASSAR M E,LAOSA O,RODRÍGUEZ MAÑAS L.Diabetes and frailty[J].Curr Opin Clin Nutr Metab Care,2019,22(1):52-57.
[7] THEOU O,HAVIVA C,WALLACE L,et al.How to construct a frailty index from an existing dataset in 10 steps[J/OL].Age Ageing,2023,52(12)[2026-05-19].https://doi.org/10.1093/ageing/afad221.
[8] ZHAO Y H,HU Y S,SMITH J P,et al.Cohort profile:the China health and retirement longitudinal study(CHARLS)[J].Int J Epidemiol,2014,43(1):61-68.
[9] SUN Y F,WANG Z B,HUANG Z Q,et al.The association between the triglyceride-to-high-density lipoprotein cholesterol ratio and the risk of progression to diabetes from prediabetes:a 5-year cohort study in Chinese adults[J/OL].Front Endocrinol,2022,13[2026-05-19].https://doi.org/10.3389/fendo.2022.947157.
[10] GUERRERO-ROMERO F,SIMENTAL-MENDÍA L E,GONZÁLEZ-ORTIZ M,et al.The product of triglycerides and glucose,a simple measure of insulin sensitivity.Comparison with the euglycemic-hyperinsulinemic clamp[J].J Clin Endocrinol Metab,2010,95(7):3347-3351.
[11] FU H L,SI L L,GUO R X.What is the optimal cut-off point of the 10-item Center for Epidemiologic Studies Depression Scale for screening depression among Chinese individuals aged 45 and over? An exploration using latent profile analysis[J/OL].Front Psychiatry,2022,13[2026-05-19].https://doi.org/10.3389/fpsyt.2022.820777.
[12] ZHAO Y C,WU S Q,LI J K,et al.Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts[J/OL].Cardiovasc Diabetol,2025,24(1)[2026-05-19].https://doi.org/10.1186/s12933-025-02880-9.
[13] ELSAYED N A,ALEPPO G,ARODA V R,et al.2.Classification and Diagnosis of Diabetes:standards of care in diabetes-2023[J].Diabetes Care,2023,46(Suppl. 1):S19-S40.
[14] LI X L,LI G L,CHENG T T,et al.Association between triglyceride-glucose index and risk of incident diabetes:a secondary analysis based on a Chinese cohort study:TyG index and incident diabetes[J/OL].Lipids Health Dis,2020,19(1)[2026-05-19].https://doi.org/10.1186/s12944-020-01403-7.
[15] PRANATA R,HUANG I,IRVAN,et al.The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus:a systematic review and dose-response meta-analysis of cohort studies[J].Endocrine,2021,74(2):254-262.
[16] GU Y Z,HAN X R,LIU J X,et al.Frailty and incident diabetes among middle-aged and older adults:Evidence from a large prospective cohort in China[J/OL].Nutr Metab Cardiovasc Dis,2025,35(10)[2026-05-19].https://doi.org/10.1016/j.numecd.2025.104114.
[17] MISHRA M,WU J,KANE A E,et al.The intersection of frailty and metabolism[J].Cell Metab,2024,36(5):893-911.
[18] FERRUCCI L,CORSI A,LAURETANI F,et al.The origins of age-related proinflammatory state[J].Blood,2005,105(6):2294-2299.
[19] VÁZQUEZ-FERNÁNDEZ A,CABALLERO F F,YÉVENES-BRIONES H,et al.Plant and animal protein intake and transitions from multimorbidity to frailty and mortality in older adults[J/OL].J Cachexia Sarcopenia Muscle,2025,16(1)[2026-05-19].https://doi.org/10.1002/jcsm.13729.
[20] 崔彦泽,张玲,蒋璐,等.衰弱与2型糖尿病的孟德尔随机化研究[J].预防医学,2024,36(9):786-789.
[1] 江燕, 王荣, 温佳鑫. 基于决策树-马尔可夫模型的南京市老年糖尿病患者肺结核筛查成本效用分析[J]. 预防医学, 2026, 38(6): 545-549.
[2] 胡建功, 张世伟, 游凯, 肖春丽, 赵红叶, 万阳, 王凤双, 彭涛, 孙昕霙. 北京市某区居民高血压、糖尿病和血脂异常共病调查[J]. 预防医学, 2026, 38(6): 614-617,621.
[3] 史耀熊, 徐洁, 王筱颖, 胡涛, 方珍. 老年糖尿病患者综合护理联合康复干预效果评价[J]. 预防医学, 2026, 38(4): 410-414.
[4] 赵锦航, 李殿江, 陈伟, 王志勇, 潘志, 刘思浚. 老年2型糖尿病患者自我效能在社会支持与抑郁症状间的中介效应分析[J]. 预防医学, 2026, 38(4): 357-361.
[5] 金茜, 叶振淼, 姜雪霞, 樊丽辉, 张默涵, 谢轶敏, 罗永园, 郑宇航. 2016—2023年温州市糖尿病发病趋势分析[J]. 预防医学, 2026, 38(4): 372-376.
[6] 李海华, 叶勇, 袁瑞, 运靖宜, 王浩博, 傅雨欣. 2006—2025年湖州市儿童青少年糖尿病发病趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(3): 257-262.
[7] 李丹, 揭金花, 李宏, 林麒, 庄海林. 老年2型糖尿病患者应对方式、日常生活活动能力在社会支持与抑郁症状间的中介效应分析[J]. 预防医学, 2026, 38(3): 279-283,290.
[8] 秦永发, 赵佳, 李辉, 陈静, 韩雪. 2010—2021年杨浦区4类慢性病过早死亡对期望寿命的影响[J]. 预防医学, 2026, 38(2): 130-134,139.
[9] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[10] 李燕冰, 周树彤, 李莹莹, 毕善琳, 李友卫. 农村中老年慢性病患者自我效能感在家庭健康与健康素养间的中介效应分析[J]. 预防医学, 2026, 38(1): 75-78,84.
[11] 徐艳平, 闫晓彤, 姚丁铭, 徐越, 张雪海, 孙洁, 徐锦杭. 浙江省中老年人肺炎疫苗接种意愿的影响因素研究[J]. 预防医学, 2025, 37(9): 881-885.
[12] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[13] 徐莉, 刘萍, 卞宇旬, 陈圆媛, 李鑫娜, 周乐. 扬州市新报告50岁及以上HIV/AIDS病例抗病毒治疗前耐药分析[J]. 预防医学, 2025, 37(8): 779-782,788.
[14] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[15] 楚楚, 徐红, 蔡波, 韩颖颖, 穆海祥, 郑会燕, 林玲. 中老年人群脑卒中风险预测模型研究[J]. 预防医学, 2025, 37(7): 649-653.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed